COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Do you or someone you know want to participate in a clinical study? See information for patients and families.

Training Materials

Contents

Online Presentations

ClinicalTrials.gov staff developed the online presentations listed below to help sponsors and investigators register studies on and submit results to ClinicalTrials.gov. PDF handouts and transcripts of each presentation are provided. The running time for each presentation is given in parentheses (minutes:seconds) after the presentation's title. Please note that the Protocol Registration and Results System (PRS) may have changed since these slides were developed.

Final Rule Webinar Series

The presentations below, originally offered as a series of three live webinars, provide responsible parties with information about the Final Rule for Clinical Trials Registration and Results Information Submission (42 CFR Part 11).

Overview of the Final Rule - Webinar 1 of 3 (60:02)
Deborah A. Zarin, MD, Director, and Rebecca J. Williams, PharmD, MPH, Assistant Director, ClinicalTrials.gov, National Library of Medicine (NLM)
Summarizes key provisions of the final rule, with a focus on the effective and compliance dates, applicability of the final rule, and new requirements for the submission of results information for applicable clinical trials of unapproved, unlicensed, or uncleared drug, biological, and device products. (September 27, 2016)

Final Rule Clinical Trial Registration Information Requirements - Webinar 2 of 3 (59:37)
Rebecca J. Williams, PharmD, MPH, Assistant Director, ClinicalTrials.gov, NLM
Summarizes who must submit "expanded" clinical trial registration information, when such information must be submitted, what constitutes registration information, and when the information must be updated. (October 5, 2016)

Final Rule Results Information Requirements - Webinar 3 of 3 (60:03)
Rebecca J. Williams, PharmD, MPH, Assistant Director, ClinicalTrials.gov, NLM
Summarizes who must submit "expanded" clinical trial results information, when such information must be submitted, what constitutes results information, and when the information must be updated.
The webinar also discussed the clinical trial information posting provisions, quality control review procedures, and when the obligation to update and correct clinical trial information ends. (October 11, 2016)

Updated Quality Control and Posting Procedures Webinar

ClinicalTrials.gov Webinar: Updated Quality Control and Posting Procedures (43:29)
Rebecca Williams, PharmD, MPH, Acting Director, ClinicalTrials.gov, NLM

On January 1, 2020, ClinicalTrials.gov will update posting procedures for submitted results information for applicable clinical trials. Consistent with 42 CFR Part 11, the National Library of Medicine (NLM) will publicly post submitted results information within 30 days of submission, regardless of whether the quality control (QC) review process is complete. This presentation describes the updated procedures and includes a question-and-answer session. (October 15, 2019)

To Top

PRS Guided Tutorials

The PRS Guided Tutorials provide step-by-step instructions for submitting registration and results information into the ClinicalTrials.gov Protocol Registration and Results System (PRS).

PRS Guided Tutorials: Include audio narration, expandable images, downloadable PDF versions, and other interactive features. [Requires a browser that supports HTML5.] If you would like to provide feedback to help us further develop content and features for the PRS Guided Tutorials, please take our survey.

To Top

Results Database Train-the-Trainer Workshop

Future Workshops

The Train-the-Trainer Workshop originally planned for May 18-19, 2020, is canceled and will be rescheduled at a later date. Updates will be provided when they are available.

This workshop is led by ClinicalTrials.gov staff and provides training to key personnel who are involved in submitting results to ClinicalTrials.gov for their academic organization (see "Who should attend?" below). It consists of interactive presentations and hands-on results data entry exercises with the Protocol Registration and Results System (PRS). The workshop topics include: the basic organizational principles of the PRS results modules, step-by-step data entry instructions for common study designs, Results Review Criteria, and navigating the ClinicalTrials.gov website help resources. The workshop will also provide an overview of key laws and policies, including the registration and results submission requirements of Section 801 of the Food and Drug Administration Amendments Act of 2007 (FDAAA 801) and its implementing regulations (42 CFR Part 11).

Who should attend?

The target attendees are personnel responsible for providing ClinicalTrials.gov training and support to others at their academic institution/organization. The workshop will provide the attendee with basic tools for helping to ensure results from their organization are successfully submitted to ClinicalTrials.gov. The workshop is best suited for individuals who have beginner or intermediate knowledge of the results database and are already familiar with the PRS, FDAAA 801, and 42 CFR Part 11.

Requirements

The workshop is free and attendees are responsible for their own travel and hotel accommodations. Attendees are required to bring their own laptop with wireless connectivity capability. Space is limited.

Workshop Materials

The materials listed below are from the workshops that were held in June and September 2015. Please note that because all workshop materials were accompanied by oral presentations, the PDF files alone may not be sufficient for understanding the requirements. In addition, the ClinicalTrials.gov website and PRS have changed since these slides were developed.

This page last reviewed in April 2020